MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation
- PMID: 16330772
- PMCID: PMC1312381
- DOI: 10.1073/pnas.0506216102
MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation
Abstract
MicroRNAs (miRs) are small noncoding RNAs that regulate gene expression primarily through translational repression. In erythropoietic (E) culture of cord blood CD34+ progenitor cells, the level of miR 221 and 222 is gradually and sharply down-modulated. Hypothetically, this decline could promote erythropoiesis by unblocking expression of key functional proteins. Indeed, (i) bioinformatic analysis suggested that miR 221 and 222 target the 3' UTR of kit mRNA; (ii) the luciferase assay confirmed that both miRs directly interact with the kit mRNA target site; and (iii) in E culture undergoing exponential cell growth, miR down-modulation is inversely related to increasing kit protein expression, whereas the kit mRNA level is relatively stable. Functional studies show that treatment of CD34+ progenitors with miR 221 and 222, via oligonucleotide transfection or lentiviral vector infection, causes impaired proliferation and accelerated differentiation of E cells, coupled with down-modulation of kit protein: this phenomenon, observed in E culture releasing endogenous kit ligand, is magnified in E culture supplemented with kit ligand. Furthermore, transplantation experiments in NOD-SCID mice reveal that miR 221 and 222 treatment of CD34+ cells impairs their engraftment capacity and stem cell activity. Finally, miR 221 and 222 gene transfer impairs proliferation of the kit+ TF-1 erythroleukemic cell line. Altogether, our studies indicate that the decline of miR 221 and 222 during exponential E growth unblocks kit protein production at mRNA level, thus leading to expansion of early erythroblasts. Furthermore, the results on kit+ erythroleukemic cells suggest a potential role of these miRs in cancer therapy.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1312381/bin/zpq0500504740001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1312381/bin/zpq0500504740002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1312381/bin/zpq0500504740003.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1312381/bin/zpq0500504740004.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1312381/bin/zpq0500504740005.gif)
Similar articles
-
miR-22 Inhibits CD34+ Cell Expansion Through Decreasing β-Catenin in Osteoblasts.Hum Gene Ther. 2017 Jan;28(1):135-145. doi: 10.1089/hum.2016.104. Epub 2016 Sep 19. Hum Gene Ther. 2017. PMID: 27762627
-
Role of Tat-interacting protein of 110 kDa and microRNAs in the regulation of hematopoiesis.Curr Opin Hematol. 2016 Jul;23(4):325-30. doi: 10.1097/MOH.0000000000000246. Curr Opin Hematol. 2016. PMID: 27071021 Review.
-
Regulation of the MIR155 host gene in physiological and pathological processes.Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Gene. 2013. PMID: 23246696 Review.
-
Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex.Haematologica. 2010 Aug;95(8):1253-60. doi: 10.3324/haematol.2009.018259. Epub 2010 Mar 19. Haematologica. 2010. PMID: 20305142 Free PMC article.
-
PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis.Oncogene. 2009 Jun 11;28(23):2276-88. doi: 10.1038/onc.2009.87. Epub 2009 May 4. Oncogene. 2009. PMID: 19421145
Cited by
-
A Review of Key Regulators of Steady-State and Ineffective Erythropoiesis.J Clin Med. 2024 Apr 27;13(9):2585. doi: 10.3390/jcm13092585. J Clin Med. 2024. PMID: 38731114 Free PMC article. Review.
-
KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST.Cell Commun Signal. 2024 Feb 27;22(1):153. doi: 10.1186/s12964-023-01411-x. Cell Commun Signal. 2024. PMID: 38414063 Free PMC article. Review.
-
Zinc Transporter ZnT1 mRNA Expression Is Negatively Associated with Leptin Serum Concentrations but Is not Associated with Insulin Resistance or Inflammatory Markers in Visceral Adipose Tissue.Biol Trace Elem Res. 2024 Feb 6. doi: 10.1007/s12011-024-04089-5. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38319549
-
The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity.Front Immunol. 2024 Jan 9;14:1320305. doi: 10.3389/fimmu.2023.1320305. eCollection 2023. Front Immunol. 2024. PMID: 38264670 Free PMC article. Review.
-
Emerging Roles of Epigenetic Regulators in Maintaining Hematopoietic Stem Cell Homeostasis.Adv Exp Med Biol. 2023;1442:29-44. doi: 10.1007/978-981-99-7471-9_3. Adv Exp Med Biol. 2023. PMID: 38228957
References
-
- Bartel, D. P. (2004) Cell 116, 281-297. - PubMed
-
- Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Radmark, O., Kim, S., et al. (2003) Nature 425, 415-419. - PubMed
-
- Ambros, V. (2004) Nature 431, 350-355. - PubMed
-
- Yekta, S., Shih, I. H. & Bartel, D. P. (2004) Science 304, 594-596. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous